ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 218 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $138,000 | +38.0% | 16,945 | +15.2% | 0.00% | – |
| Q2 2020 | $100,000 | -3.8% | 14,715 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $104,000 | -27.8% | 14,715 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $144,000 | -20.9% | 14,715 | -11.3% | 0.00% | 0.0% |
| Q3 2019 | $182,000 | -15.7% | 16,595 | -10.7% | 0.00% | 0.0% |
| Q2 2019 | $216,000 | -12.2% | 18,590 | -28.0% | 0.00% | 0.0% |
| Q1 2019 | $246,000 | -1.2% | 25,810 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $249,000 | -86.8% | 25,810 | -80.4% | 0.00% | -83.3% |
| Q3 2018 | $1,880,000 | +18.5% | 131,905 | -0.2% | 0.01% | +9.1% |
| Q2 2018 | $1,586,000 | +6.7% | 132,205 | +9.8% | 0.01% | 0.0% |
| Q1 2018 | $1,487,000 | +12.6% | 120,410 | +32.7% | 0.01% | +22.2% |
| Q4 2017 | $1,321,000 | +187.8% | 90,765 | +181.4% | 0.01% | +200.0% |
| Q3 2017 | $459,000 | +11.4% | 32,250 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $412,000 | +2.0% | 32,250 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $404,000 | +22.1% | 32,250 | -0.4% | 0.00% | 0.0% |
| Q4 2016 | $331,000 | -19.7% | 32,385 | +3.6% | 0.00% | -25.0% |
| Q3 2016 | $412,000 | +3.8% | 31,250 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $397,000 | -3.9% | 31,250 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $413,000 | -14.1% | 31,250 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $481,000 | +24.3% | 31,250 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $387,000 | -17.3% | 31,250 | -8.8% | 0.00% | +200.0% |
| Q2 2015 | $468,000 | +4.9% | 34,250 | -8.4% | 0.00% | 0.0% |
| Q1 2015 | $446,000 | +1.8% | 37,375 | +8.7% | 0.00% | 0.0% |
| Q4 2014 | $438,000 | +4.3% | 34,375 | +9.6% | 0.00% | 0.0% |
| Q3 2014 | $420,000 | -16.5% | 31,375 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $503,000 | -11.1% | 31,375 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $566,000 | +16.9% | 31,375 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $484,000 | +3.9% | 31,375 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $466,000 | +58.0% | 31,375 | +37.2% | 0.00% | 0.0% |
| Q2 2013 | $295,000 | – | 22,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |